Information Provided By:
Fly News Breaks for October 1, 2019
ACAD
Oct 1, 2019 | 05:20 EDT
RBC Capital started Acadia Pharmaceuticals with an Outperform rating and $60 price target.
News For ACAD From the Last 2 Days
There are no results for your query ACAD